Eli Lilly violates patients' privacyBMJ 2001; 323 doi: https://doi.org/10.1136/bmj.323.7304.65/a (Published 14 July 2001) Cite this as: BMJ 2001;323:65
- Gavin Yamey
- San Francisco
The drug company Eli Lilly, which manufactures fluoxetine (Prozac), has admitted that it violated its own policy on patient confidentiality by publicising the email addresses of over 700 patients taking the drug.
For the past two years the company has offered patients taking fluoxetine an email reminder service (Medi-messenger). Patients decided what kind of reminder they wanted, …
Log in using your username and password
Log in through your institution
Register for a free trial to thebmj.com to receive unlimited access to all content on thebmj.com for 14 days.
Sign up for a free trial